Insider · CIK 0001799357
Hassard James
Reports to the SEC for 2 companies · PASADENA, CA
Transactions
14
Companies
2
Filings
8
CIK
0001799357
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-07-05 | CRNXCrinetics Pharmaceuticals, Inc.M Exercise/Conversion | +$296K |
| 2024-07-05 | CRNXCrinetics Pharmaceuticals, Inc.S Sale | −$661K |
| 2024-07-05 | CRNXCrinetics Pharmaceuticals, Inc. · Stock option (Right to Buy)M Exercise/Conversion | — |
| 2024-06-21 | CRNXCrinetics Pharmaceuticals, Inc.M Exercise/Conversion | +$296K |
| 2024-06-21 | CRNXCrinetics Pharmaceuticals, Inc.S Sale | −$670K |
| 2024-06-21 | CRNXCrinetics Pharmaceuticals, Inc. · Stock option (Right to Buy)M Exercise/Conversion | — |
| 2024-03-18 | CRNXCrinetics Pharmaceuticals, Inc.F Tax Payment | −$66.4K |
| 2024-03-04 | CRNXCrinetics Pharmaceuticals, Inc.A Award | — |
| 2024-03-04 | CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2023-03-01 | CRNXCrinetics Pharmaceuticals, Inc.A Award | — |
| 2023-03-01 | CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2022-03-10 | CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2021-06-22 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$323K |
| 2021-01-07 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$1.17M |
Recent filings
- 4Hassard James0000950170-24-082529SEC(opens sec.gov)
- 4Hassard James0000950170-24-076871SEC(opens sec.gov)
- 4Hassard James0001209191-24-005011SEC(opens sec.gov)
- 4Hassard James0001209191-24-004612SEC(opens sec.gov)
- 4Hassard James0001209191-23-015619SEC(opens sec.gov)
- 4Hassard James0001209191-22-017938SEC(opens sec.gov)
- 4Hassard James0001209191-21-043137SEC(opens sec.gov)
- 4Hassard James0001209191-21-002801SEC(opens sec.gov)
Companies
Address
177 E COLORADO BLVD STE 700
PASADENA, CA, 91105